Costs and Expenses in USD of AbbVie Inc. from 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
AbbVie Inc. quarterly and annual Costs and Expenses history and change rate from 2011 to Q3 2025.
  • AbbVie Inc. Costs and Expenses for the quarter ending 30 Sep 2025 was $13,872,000,000, a 31% increase year-over-year.
  • AbbVie Inc. Costs and Expenses for the twelve months ending 30 Sep 2025 was $50,603,000,000, a 21% increase year-over-year.
  • AbbVie Inc. annual Costs and Expenses for 2024 was $47,197,000,000, a 14% increase from 2023.
  • AbbVie Inc. annual Costs and Expenses for 2023 was $41,561,000,000, a 4.1% increase from 2022.
  • AbbVie Inc. annual Costs and Expenses for 2022 was $39,937,000,000, a 4.3% increase from 2021.
Source SEC data
View on sec.gov
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Change (%)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Change (%)

AbbVie Inc. Quarterly Costs and Expenses (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $50,603,000,000 $13,872,000,000 +$3,243,000,000 +31% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $47,360,000,000 $10,529,000,000 +$65,000,000 +0.62% 01 Apr 2025 30 Jun 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 $47,295,000,000 $9,610,000,000 +$98,000,000 +1% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $47,197,000,000 $16,592,000,000 +$5,486,000,000 +49% 01 Oct 2024 31 Dec 2024 10-K 14 Feb 2025 2024 FY
Q3 2024 $41,711,000,000 $10,629,000,000 -$1,017,000,000 -8.7% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 $42,728,000,000 $10,464,000,000 +$1,112,000,000 +12% 01 Apr 2024 30 Jun 2024 10-Q 04 Aug 2025 2025 Q2
Q1 2024 $41,616,000,000 $9,512,000,000 +$55,000,000 +0.58% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1
Q4 2023 $41,561,000,000 $11,106,000,000 +$1,487,000,000 +15% 01 Oct 2023 31 Dec 2023 10-K 14 Feb 2025 2024 FY
Q3 2023 $40,074,000,000 $11,646,000,000 +$1,437,000,000 +14% 01 Jul 2023 30 Sep 2023 10-Q 04 Nov 2024 2024 Q3
Q2 2023 $38,637,000,000 $9,352,000,000 -$1,936,000,000 -17% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 $40,573,000,000 $9,457,000,000 +$636,000,000 +7.2% 01 Jan 2023 31 Mar 2023 10-Q 03 May 2024 2024 Q1
Q4 2022 $39,937,000,000 $9,619,000,000 -$193,000,000 -2% 01 Oct 2022 31 Dec 2022 10-K 14 Feb 2025 2024 FY
Q3 2022 $40,130,000,000 $10,209,000,000 +$173,000,000 +1.7% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023 2023 Q3
Q2 2022 $39,957,000,000 $11,288,000,000 +$1,770,000,000 +19% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023 2023 Q2
Q1 2022 $38,187,000,000 $8,821,000,000 -$86,000,000 -0.97% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023 2023 Q1
Q4 2021 $38,273,000,000 $9,812,000,000 -$293,000,000 -2.9% 01 Oct 2021 31 Dec 2021 10-K 20 Feb 2024 2023 FY
Q3 2021 $38,566,000,000 $10,036,000,000 +$389,000,000 +4% 01 Jul 2021 30 Sep 2021 10-Q 04 Nov 2022 2022 Q3
Q2 2021 $38,177,000,000 $9,518,000,000 -$155,000,000 -1.6% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 $38,332,000,000 $8,907,000,000 +$3,891,000,000 +78% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q4 2020 $34,441,000,000 $10,105,000,000 +$5,357,000,000 +113% 01 Oct 2020 31 Dec 2020 10-K 17 Feb 2023 2022 FY
Q3 2020 $29,084,000,000 $9,647,000,000 +$3,785,000,000 +65% 01 Jul 2020 30 Sep 2020 10-Q 02 Nov 2021 2021 Q3
Q2 2020 $25,299,000,000 $9,673,000,000 +$4,818,000,000 +99% 01 Apr 2020 30 Jun 2020 10-Q 02 Aug 2021 2021 Q2
Q1 2020 $20,481,000,000 $5,016,000,000 +$198,000,000 +4.1% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021 2021 Q1
Q4 2019 $20,283,000,000 $4,748,000,000 -$5,998,000,000 -56% 01 Oct 2019 31 Dec 2019 10-K 18 Feb 2022 2021 FY
Q3 2019 $26,281,000,000 $5,862,000,000 +$785,000,000 +15% 01 Jul 2019 30 Sep 2019 10-Q 04 Nov 2020 2020 Q3
Q2 2019 $25,496,000,000 $4,855,000,000 -$661,000,000 -12% 01 Apr 2019 30 Jun 2019 10-Q 04 Aug 2020 2020 Q2
Q1 2019 $26,157,000,000 $4,818,000,000 -$213,000,000 -4.2% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q4 2018 $26,370,000,000 $10,746,000,000 +$4,789,000,000 +80% 01 Oct 2018 31 Dec 2018 10-K 19 Feb 2021 2020 FY
Q3 2018 $21,581,000,000 $5,077,000,000 +$776,000,000 +18% 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019 2019 Q3
Q2 2018 $20,805,000,000 $5,516,000,000 +$1,234,000,000 +29% 01 Apr 2018 30 Jun 2018 10-Q 05 Aug 2019 2019 Q2
Q1 2018 $19,571,000,000 $5,031,000,000 +$900,000,000 +22% 01 Jan 2018 31 Mar 2018 10-Q 03 May 2019 2019 Q1
Q4 2017 $18,671,000,000 $5,957,000,000 +$1,475,000,000 +33% 01 Oct 2017 31 Dec 2017 10-K 21 Feb 2020 2019 FY
Q3 2017 $17,196,000,000 $4,301,000,000 +$230,000,000 +5.6% 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2018 Q3
Q2 2017 $16,966,000,000 $4,282,000,000 +$217,000,000 +5.3% 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2018 2018 Q2
Q1 2017 $16,749,000,000 $4,131,000,000 +$451,000,000 +12% 01 Jan 2017 31 Mar 2017 10-Q 04 May 2018 2018 Q1
Q4 2016 $16,298,000,000 $4,482,000,000 +$195,000,000 +4.5% 01 Oct 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
Q3 2016 $16,103,000,000 $4,071,000,000 +$12,000,000 +0.3% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2017 2017 Q3
Q2 2016 $16,091,000,000 $4,065,000,000 +$442,000,000 +12% 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017 2017 Q2
Q1 2016 $15,649,000,000 $3,680,000,000 +$327,000,000 +9.8% 01 Jan 2016 31 Mar 2016 10-Q 05 May 2017 2017 Q1
Q4 2015 $15,322,000,000 $4,287,000,000 -$1,580,000,000 -27% 01 Oct 2015 31 Dec 2015 10-K 16 Feb 2018 2017 FY
Q3 2015 $16,902,000,000 $4,059,000,000 $0 0% 01 Jul 2015 30 Sep 2015 10-Q 07 Nov 2016 2016 Q3
Q2 2015 $16,902,000,000 $3,623,000,000 +$212,000,000 +6.2% 01 Apr 2015 30 Jun 2015 10-Q 05 Aug 2016 2016 Q2
Q1 2015 $16,690,000,000 $3,353,000,000 +$141,000,000 +4.4% 01 Jan 2015 31 Mar 2015 10-Q 06 May 2016 2016 Q1
Q4 2014 $16,549,000,000 $5,867,000,000 +$2,291,000,000 +64% 01 Oct 2014 31 Dec 2014 10-K 17 Feb 2017 2016 FY
Q3 2014 $14,258,000,000 $4,059,000,000 +$772,000,000 +23% 01 Jul 2014 30 Sep 2014 10-Q 06 Nov 2015 2015 Q3
Q2 2014 $13,486,000,000 $3,411,000,000 +$172,000,000 +5.3% 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2015 2015 Q2
Q1 2014 $13,314,000,000 $3,212,000,000 +$188,000,000 +6.2% 01 Jan 2014 31 Mar 2014 10-Q 08 May 2015 2015 Q1
Q4 2013 $13,126,000,000 $3,576,000,000 +$191,000,000 +5.6% 01 Oct 2013 31 Dec 2013 10-K 19 Feb 2016 2015 FY
Q3 2013 $12,935,000,000 $3,287,000,000 +$375,000,000 +13% 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014 2014 Q3
Q2 2013 $12,560,000,000 $3,239,000,000 +$168,000,000 +5.5% 01 Apr 2013 30 Jun 2013 10-Q 07 Aug 2014 2014 Q2
Q1 2013 $12,392,000,000 $3,024,000,000 -$171,000,000 -5.4% 01 Jan 2013 31 Mar 2013 10-Q 09 May 2014 2014 Q1
Q4 2012 $12,563,000,000 $3,385,000,000 01 Oct 2012 31 Dec 2012 10-K 20 Feb 2015 2014 FY
Q3 2012 $2,912,000,000 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013 2013 Q3
Q2 2012 $3,071,000,000 01 Apr 2012 30 Jun 2012 10-Q 09 Aug 2013 2013 Q2
Q1 2012 $3,195,000,000 01 Jan 2012 31 Mar 2012 10-Q 08 May 2013 2013 Q1

AbbVie Inc. Annual Costs and Expenses (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $47,197,000,000 +$5,636,000,000 +14% 01 Jan 2024 31 Dec 2024 10-K 14 Feb 2025 2024 FY
2023 $41,561,000,000 +$1,624,000,000 +4.1% 01 Jan 2023 31 Dec 2023 10-K 14 Feb 2025 2024 FY
2022 $39,937,000,000 +$1,664,000,000 +4.3% 01 Jan 2022 31 Dec 2022 10-K 14 Feb 2025 2024 FY
2021 $38,273,000,000 +$3,832,000,000 +11% 01 Jan 2021 31 Dec 2021 10-K 20 Feb 2024 2023 FY
2020 $34,441,000,000 +$14,158,000,000 +70% 01 Jan 2020 31 Dec 2020 10-K 17 Feb 2023 2022 FY
2019 $20,283,000,000 -$6,087,000,000 -23% 01 Jan 2019 31 Dec 2019 10-K 18 Feb 2022 2021 FY
2018 $26,370,000,000 +$7,699,000,000 +41% 01 Jan 2018 31 Dec 2018 10-K 19 Feb 2021 2020 FY
2017 $18,671,000,000 +$2,373,000,000 +15% 01 Jan 2017 31 Dec 2017 10-K 21 Feb 2020 2019 FY
2016 $16,298,000,000 +$976,000,000 +6.4% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
2015 $15,322,000,000 -$1,227,000,000 -7.4% 01 Jan 2015 31 Dec 2015 10-K 16 Feb 2018 2017 FY
2014 $16,549,000,000 +$3,423,000,000 +26% 01 Jan 2014 31 Dec 2014 10-K 17 Feb 2017 2016 FY
2013 $13,126,000,000 +$563,000,000 +4.5% 01 Jan 2013 31 Dec 2013 10-K 19 Feb 2016 2015 FY
2012 $12,563,000,000 -$1,261,000,000 -9.1% 01 Jan 2012 31 Dec 2012 10-K 20 Feb 2015 2014 FY
2011 $13,824,000,000 01 Jan 2011 31 Dec 2011 10-K 21 Feb 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.